Satyadeva Organosys Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 7.48 Cr
as on 15-12-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2019)
- Profit 73.57%
(FY 2019)
- Ebitda 73.57%
(FY 2019)
- Net Worth -11.10%
(FY 2019)
- Total Assets 1.66%
(FY 2019)
About Satyadeva Organosys
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.48 Cr, as per Ministry of Corporate Affairs (MCA) records.
Gaddam Ramana, Venkptarama Gaddam, Kandula Mohan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232TG2010PTC071883
- Company No.
071883
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Dec 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Satyadeva Organosys?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Gaddam Ramana | Director | 27-Dec-2010 | Current |
Venkptarama Gaddam | Director | 27-Dec-2010 | Current |
Kandula Mohan | Additional Director | 15-Apr-2015 | Current |
Varaprasada Valluru | Additional Director | 15-Apr-2015 | Current |
Girijalakshmi Kolluri | Additional Director | 07-Feb-2022 | Current |
Financial Performance of Satyadeva Organosys.
Satyadeva Organosys Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 73.57% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.1%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Satyadeva Organosys?
In 2019, Satyadeva Organosys had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Vineet Life Sciences Private LimitedActive 10 years 11 months
Gaddam Ramana, Kandula Mohan and 1 more are mutual person
- Vineet Chem Trade Private LimitedActive 9 years 7 months
Gaddam Ramana and Venkptarama Gaddam are mutual person
- Taar Hotals And Resorts Private LimitedActive 2 years 3 months
Girijalakshmi Kolluri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Satyadeva Organosys?
Unlock and access historical data on people associated with Satyadeva Organosys, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Satyadeva Organosys, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Satyadeva Organosys's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.